Xenon Pharmaceuticals
XENE
XENE
246 hedge funds and large institutions have $3.78B invested in Xenon Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.06% less ownership
Funds ownership: 109.36% → 109.29% (-0.06%)
34% less call options, than puts
Call options by funds: $36.4M | Put options by funds: $54.7M
Holders
246
Holding in Top 10
9
Calls
$36.4M
Puts
$54.7M
Top Buyers
| 1 | +$48.5M | |
| 2 | +$34.5M | |
| 3 | +$20.6M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$18.5M |
| 5 |
Two Sigma Investments
New York
|
+$18.3M |
Top Sellers
| 1 | -$74.8M | |
| 2 | -$37.8M | |
| 3 | -$35M | |
| 4 |
Millennium Management
New York
|
-$31.5M |
| 5 |
Holocene Advisors
New York
|
-$29.2M |
